Rubin Marc 4

What Happened

• Marc Rubin, a director of Curis, Inc. (CRIS), acquired 26,667 shares of common stock on March 20, 2026 through the automatic conversion of Series B Convertible Non‑Redeemable Preferred Stock into common shares. The conversion occurred at no additional consideration under the company's Certificate of Designations.
• The Form 4 also reports a small, separate disposition of 20 shares on the same date labeled as a derivative conversion; the filing does not explain that line item.

Key Details

• Transaction date: March 20, 2026; Form 4 filed March 23, 2026 (filed within the normal two-business‑day Form 4 deadline).
• Acquired: 26,667 common shares via conversion (no cash paid at conversion).
• Disposed: 20 common shares (derivative conversion line; reason not specified).
• Original purchase: The footnote states the Reporting Person bought each “Security” (one Series B Preferred plus associated warrants) for $1,000. Each Series B preferred converts into 1,333.33 common shares, implying Rubin purchased 20 Securities (20 × 1,333.33 ≈ 26,667 shares) for $20,000 total — an implied cost of about $0.75 per common share (the conversion itself required no additional payment).
• Shares owned after the transaction: not specified in the filing.
• Notable terms: The automatic conversion was subject to the Certificate of Designations and applicable Beneficial Ownership Limitations.

Context

• This was a conversion of preferred shares into common stock (a non‑cash transaction), not an open‑market purchase or sale. Conversions like this increase an insider’s common‑stock holdings but do not necessarily signal a buy/sell decision by the insider.
• The filing includes warrants that accompanied the preferred shares, but the reported Form 4 entries relate to the preferred‑to‑common conversion; no exercise of warrants or open‑market trades are shown.